FindTrial
Sign In

Behaviour modification in Diabetes

A Randomized Comparative Control Trial To Evaluate The Efficacy of Educational Interventional Module(EIM) With Triphaladi Granules on Premeha(Diabetes) - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060842
Enrollment
200
Registered
2023-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.elevated FPG (=126 mg/dL and =200 mg/dL) measured at screening, 2.Random blood sugar and Postprandial blood sugar =200 mg/dL and =350 3.Hba1c =6.5% and =10%

Exclusion criteria

Exclusion criteria: 1. Patients with acute/chronic liver disease with elevated liver enzymes. 2. Patients with history of alcohol abuse. 3. Patients having insulin dependent DM (type 1) and receiving insulin 4. Diagnosed Chronic complications like microvascular and macrovascular derangements. 5. Hyper or hypothyroidism 6. Patients reporting to be hypersensitive to any of the proposed trial drugs. 7. Patients on vitamin B supplementation, NSAIDs.

Design outcomes

Primary

MeasureTime frame
1. Decrease in Blood sugar fasting, post prandial 2. Decrease in Glycosylated hemoglobinTimepoint: 0,30th, 60th and 90th—

Secondary

MeasureTime frame
Change in Quality of LifeTimepoint: 0,30th, 60th & 90th—

Countries

India

Contacts

Public ContactAnkita Rai

All India Institute of Ayurveda

Shivakumarsharti@gmail.com9611275434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026